Innovating Works

ADVANCED MARKER DISCOVERY

Activa
ColoDix: Disruptive and high accuracy test for early colorectal cancer detection in blood ADVANCED MARKER DISCOVERY tramitó un HORIZON EUROPE: HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 AMADIX is a leading molecular diagnostics company, led by Rocío Arroyo, focused on liquid biopsy, developing innovative diagnostic tests for...
2022-07-22 - 2024-07-31 | Financiado
AMX DATA: Identification of risk factors for the development of colorectal cancer and or premalignant lesion... ADVANCED MARKER DISCOVERY tramitó un H2020: H2020-INNOSUP-2018-2020 Founded in 2010, AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for earl...
2020-09-15 - 2021-12-31 | Financiado
ColoFast: Developing a Non Invasive Kit for Early Colorectal Cancer Detection ADVANCED MARKER DISCOVERY tramitó un H2020: H2020-SMEInst-2016-2017 Colorectal cancer (CRC) represents one of the most important health problems worldwide. Decreasing the mortality rate by CRC in Europe is a...
2017-06-23 - 2021-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.